Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.

Introduction The availability of e-cigarettes has profoundly changed the tobacco product landscape. In the US, almost 6 million adults use both combustible and electronic cigarettes (i.e., dual users). The goal of this study is to understand how smokers and dual users differ in terms of demographics, cigarette dependence, and exposure to carcinogens. Methods An observational cohort (smokers, n=166, ≥5 cigarettes/day for 6 months and no e-cigarette use in 3 months; dual users, n=256, smoked daily for 3 months and used e-cigarettes at least once/week for the past 3 months) completed baseline assessments of demographics, tobacco use, and dependence. They also provided breath samples for carbon monoxide (CO) assay and urine samples for cotinine, 3-hydroxycotinine (3HC), and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) assays. Results Compared to smokers, dual users (mean e-cigarette use=5.5 days/week [SD=1.9]) were significantly younger and more likely to be white, have more education, report a history of psychiatric co-morbidity, and smoke fewer cigarettes/day. There were no differences in CO, cotinine, or 3HC levels; however, dual users had significantly lower levels of NNAL than did smokers. Most smokers and dual users had no plans to quit smoking within the next year; 91% of dual users planned to continue using ECs for at least the next year. Conclusions In this community sample, dual users are supplementing their smoking with e-cigarette use. Dual users, versus smokers, smoked fewer cigarettes per day and delayed their first cigarette of the day, but did not differ in quitting intentions. Implications This comparison of a community sample of established dual users and exclusive smokers addresses key questions of dependence and health risks of dual use in real-world settings. Dual users were more likely to be white, younger, have more than a high school education and have a psychiatric history. Dual users also smoked significantly fewer cigarettes and had lower levels of NNAL (a carcinogen), but they did not differ from exclusive smokers in carbon monoxide or cotinine levels, suggesting that they supplemented their nicotine intake via e-cigarettes.

[1]  N. Benowitz,et al.  Nicotine Intake, Dependence, and Characteristics of Electronic Cigarette and Dual Users , 2019, Tobacco Regulatory Science.

[2]  T. Pechacek,et al.  Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015–2016 , 2018, PloS one.

[3]  I. Rahman,et al.  Does E-cigarette Use at Baseline Influence Smoking Cessation Rates among 2-Year College Students? , 2018, Journal of smoking cessation.

[4]  J. Gordon,et al.  Dual- and Polytobacco/Nicotine Product Use Trends in a National Sample of High School Students , 2018, American journal of health promotion : AJHP.

[5]  M. Noland,et al.  Current Use of E-Cigarettes and Conventional Cigarettes Among US High School Students in Urban and Rural Locations: 2014 National Youth Tobacco Survey , 2018, American journal of health promotion : AJHP.

[6]  T. Brandon,et al.  Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient‐provider communication , 2018, Psycho-oncology.

[7]  Arielle S. Selya,et al.  Evaluating the mutual pathways among electronic cigarette use, conventional smoking and nicotine dependence , 2018, Addiction.

[8]  A. Hackshaw,et al.  Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports , 2018, British Medical Journal.

[9]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.

[10]  F. Baeyens,et al.  Differences between Dual Users and Switchers Center around Vaping Behavior and Its Experiences Rather than Beliefs and Attitudes , 2017, International journal of environmental research and public health.

[11]  D. Duncan,et al.  Characteristics of Adults Who Switched From Cigarette Smoking to E-cigarettes. , 2017, American journal of preventive medicine.

[12]  S. Campostrini,et al.  Electronic cigarette use as an aid to quit smoking in the representative Italian population PASSI survey. , 2017, Preventive medicine.

[13]  QuickStats: Percentage of Adults Who Ever Used an E-cigarette and Percentage Who Currently Use E-cigarettes, by Age Group — National Health Interview Survey, United States, 2016 , 2017, MMWR. Morbidity and mortality weekly report.

[14]  Shu-Hong Zhu,et al.  E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys , 2017, British Medical Journal.

[15]  Woon-Puay Koh,et al.  CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study , 2017, Carcinogenesis.

[16]  L. Brose,et al.  What factors are associated with current smokers using or stopping e-cigarette use? , 2017, Drug and alcohol dependence.

[17]  S. H. Park,et al.  Patterns of electronic cigarette use and level of psychological distress , 2017, PloS one.

[18]  R. West,et al.  Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users , 2017, Annals of Internal Medicine.

[19]  A. Coyle,et al.  ‘A good method of quitting smoking’ or ‘just an alternative to smoking’? Comparative evaluations of e-cigarette and traditional cigarette usage by dual users , 2017, Health psychology open.

[20]  N. Benowitz,et al.  Nicotine Delivery and Vaping Behavior During ad Libitum E-cigarette Access. , 2016, Tobacco regulatory science.

[21]  Robert West,et al.  Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends , 2016, British Medical Journal.

[22]  L. Hawk,et al.  Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking , 2016, Pharmacology Biochemistry and Behavior.

[23]  C. la Vecchia,et al.  Cohort study of electronic cigarette use: effectiveness and safety at 24 months , 2016, Tobacco Control.

[24]  S. Hecht,et al.  Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines. , 2016, Accounts of chemical research.

[25]  T. Brandon,et al.  E-cigarettes and expectancies: why do some users keep smoking? , 2015, Addiction.

[26]  C. Schoenborn,et al.  Electronic Cigarette Use Among Adults: United States, 2014. , 2015, NCHS data brief.

[27]  R. West,et al.  Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1‐year follow‐up , 2015, Addiction.

[28]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.

[29]  A. Gamst,et al.  Use of e-cigarettes by individuals with mental health conditions , 2014, Tobacco Control.

[30]  K. Fagerström Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. , 2012, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  J. Etter,et al.  Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. , 2011, Addiction.

[32]  N. Benowitz,et al.  Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  N. Benowitz,et al.  Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. , 2008, Analytical chemistry.

[34]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[35]  Megan E. Piper,et al.  A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). , 2004, Journal of consulting and clinical psychology.

[36]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.